Accurate modeling of metabolic pathways for drug target identification and industrial production processes
25 July 2022
PEACCEL and partners underline in the June 2022 issue of the peer-
reviewed journal Frontiers in Artificial intelligence how non-linearity is crucial when
modeling metabolic pathways for the identification of biomarkers of diseases or
optimizing industrial production processes.
- The Entamoeba histolytica glycolysis, one of the major metabolic pathways of the parasite
- The peroxide detoxification pathway of Trypanosoma cruzi
- The industrial-scale penicillin fermentation process of Penicillium chrysogenum
PEACCEL co-authored a critical review on VHH structural modelling approaches with its academic partners
18 July 2022
VHH, i.e., VH domains of camelid single-chain antibodies, are very promising therapeutic agents due to their significant physicochemical advantages compared to classical mammalian antibodies. Unfortunately, most VHHs do not have 3D structures. This review presents the most extensive overview of structure prediction methods applied for the 3D modelling of a given VHH sequence (a total of 21). AlphaFold 2 and NanoNet appear to be the best tools to predict a structural model of VHH from its sequence.
PEACCEL and SYNTHELIS have signed a strategic partnership to increase the chances of success of your drugs
12 May 2022
PEACCEL and SYNTHELIS have signed a strategic partnership to offer their clients and partners a one-stop shop combining Artificial Intelligence (AI) and Cell-Free lead expression for accelerated drug discovery.
PEACCEL has just received the award “Life Sciences AI company of the Year” from CorporateLiveWire !
27 August 2021
PEACCEL listed in The Digest of Global AI in Pharma Investment
4 August 2021
PEACCEL is listed in The Digest of Global AI in Pharma Investment.https://www.linkedin.com/posts/alina-timoshenkova-5b0a6364_top-countries-in-ai-for-drug-discovery-sector-activity-6828674970089078784-xobr/
PEACCEL mentioned as a AI start-up to watch by NVIDIA
6 April 2021
PEACCEL mentioned as a AI start-up to watch by NVIDIA.Three Trends for Healthcare AI Startups To Watch Renee Y. | 19 mars 2021